To help you get the practical information you need to speed the recovery of your practice, on Tuesday, June 9, MedPB is hosting a webinar that pulls in top experts to walk you through what you need to know and do to put together your 90-day recovery plan.
The FDA has cleared the MED-EL ADHEAR, an innovative non-surgical bone conduction solution for conductive hearing loss. Described as the “next generation of non-surgical bone conduction hearing technology,” it consists of a patented adhesive adapter that is placed onto the skin behind the ear and is worn for 3 to 7 days at a time. The lightweight audio processor is simply clicked on and off the adapter each day.
Hearing Health & Technology Matters (HHTM) announced the release of results of a survey of audiologists regarding their experience with hearing aid maintenance and repair over the past year (2019), prior to the COVID-19 pandemic.
How can we track auditory ecology in hearing aid use? This pilot study pilot study by Danielle Glista, PhD, and her colleagues from Western and Wilfrid Laurier Universities and Unitron Canada looks at the various forms of big-data collection and analysis for increasing the performance of hearing aids.
PEDMARK is said to be an investigational drug for the prevention of ototoxicity induced by cisplatin chemotherapy in patients one month to <18 years of age with localized, non-metastatic, solid tumors.